Covering the subjects at the forefront of disease therapy, our new PharmaFocus report series aims to provide management-level healthcare professionals with a clear understanding of the industry issues that matter the most.
Each report in the series offers highly detailed analysis on key subjects in the pharmaceutical sector – ranging from coverage of a particular segment of an individual disease market, to a specific therapeutic area involving multiple diseases.
Dr. Ramya Kartikeyan, Senior Analyst of Infectious Disease Team, says: “Pharmaceutical companies rely on making decisions based on fast-paced technological trends and innovations. With the PharmaFocus series, we are attempting to offer products that are tailored to answer these unmet needs of our ever-growing client base.”
PharmaFocus reports are built around interviews with Key Opinion Leaders (KOLs) and supported by an expert team of healthcare analysts, ensuring that clients receive the most accurate and informed industry insights possible.
Focusing on the future of the healthcare industry, early stage R&D forms a vital part of the new series, supplying clients with a sound understanding of the research that will form the next generation of pharmaceutical development.
“These reports focus on specific aspects of the developmental and regulatory pathways required for these companies to obtain clinical and commercial success. They include key quotes from globally renowned KOLs, help to provide insight to clients at either end of the spectrum, clinical research and discovery to commercialization and corporate development,” explains Dr. Kartikeyan
The first of the PharmaFocus series, entitled Vaccine Adjuvants in Infectious Disease is available from GlobalData’s ReportStore now. Reports on Biomarkers in Alzheimers’ Disease, Market Access Strategies in Infectious Disease and Public-Private Partnerships will be available over the next few months